Sputnik World's First Coronavirus Vaccine Ready In Russia

The world’s eyes are turning towards Russia, which has finally managed to produce the first certified and reliable vaccine for the emerging corona virus, which bore the name “Sputnik”, after Russian President Vladimir Putin announced today, Tuesday, that his country has developed the first vaccine that provides “sustainable immunity” against Corona, at a time.

According to alqabas, The world is suffering due to the increase in cases and deaths due to the virus that struck various parts of the world. Great confidence “This morning, for the first time in the world, a vaccine against the emerging corona virus was registered” in Russia, Putin said during a video call with his government ministers, stressing that the vaccine had undergone the necessary checks, pointing out that one of his daughters received a dose of the vaccine and she is in good health.

The Russian president indicated that the new vaccine has not completed clinical trials yet, but it works “effectively enough”, according to the American “New York Times” newspaper. The new Russian vaccine developed by the Gamalia Institute in Moscow – less than two months after it was tested on humans – is the first vaccine of its kind to be registered and approved for production in the world, at a time when many virus vaccines are subjected to clinical trials.

Two years immunity In a related development, the Ministry of Health in Russia indicated that Moscow will produce the vaccine in large quantities by next September, adding that it bids requests for one billion doses of the new vaccine. The Russian Ministry of Health stated in a statement on its website, that the vaccine gives humans immunity for two years from the emerging virus, adding that the mass vaccination process will start in early January. Questionable reports In the same context, the US network “CNN” revealed concerns indicated by reports about its safety and effectiveness. Volume 0%   Scientists in the West are skeptical about the speed of Russia’s development of the vaccine, indicating that researchers may have abbreviated the required experiments before the start of circulation of the vaccine after they were subjected to pressure, according to the BBC

Comments Post Comment

Leave a Comment

Submit